Home
HelpOrder Code LAB1371 Homocysteine, Total, Plasma
Reporting Name
Homocysteine, Total, PUseful For
An aid for screening patients suspected of having an inherited disorder of methionine metabolism including:
-Cystathionine beta-synthase deficiency (homocystinuria)
-Methylenetetrahydrofolate reductase deficiency and its thermolabile variants
-Methionine synthase deficiency
-Cobalamin (Cbl) metabolism
-Combined methyl-Cbl and adenosyl-Cbl deficiencies: Cbl C2, Cbl D2, and Cbl F3 deficiencies
-Methyl-Cbl specific deficiencies: Cbl D-Var1, Cbl E, and Cbl G deficiencies
-Transcobalamin II deficiency
-Adenosylhomocysteinase deficiency
-Glycine N-methyltransferase deficiency
-Methionine adenosyltransferase I/III deficiency
Screening and monitoring patients suspected of, or confirmed with, an inherited disorder of methionine metabolism
Evaluating individuals with suspected deficiency of vitamin B12 or folate
Performing Laboratory
Mayo Clinic Laboratories in Rochester
Specimen Type
Plasma EDTANecessary Information
1. Patient's age and sex are required.
2. Biochemical Genetics Patient Information (T602) is recommended, but not required, for suspected cases of inherited disorders of methionine metabolism.
Specimen Required
Collection Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Green top (sodium or lithium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Immediately place specimen on wet ice.
2. Centrifuge and aliquot plasma into plastic vial within 4 hours of collection.
3. If blood cannot be placed on wet ice immediately, centrifuge and aliquot plasma into plastic vial within 1 hour of collection.
4. A refrigerated centrifuge is not required if the above time restrictions are met.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Plasma EDTA | Refrigerated (preferred) | 28 days | |
| Frozen | 309 days | ||
| Ambient | 28 days |
Reference Values
|
Age |
Total homocysteine (nmol/mL) |
|
|
Female |
Male |
|
|
0-11 months |
3.1-8.3 |
3.2-9.7 |
|
12-23 months |
3.2-8.3 |
3.3-9.6 |
|
24-35 months |
3.2-8.2 |
3.3-9.6 |
|
3 years |
3.2-8.2 |
3.3-9.6 |
|
4 years |
3.3-8.2 |
3.4-9.5 |
|
5 years |
3.4-8.1 |
3.5-9.4 |
|
6 years |
3.5-8.1 |
3.6-9.4 |
|
7 years |
3.5-8.1 |
3.7-9.4 |
|
8 years |
3.6-8.2 |
3.8-9.3 |
|
9 years |
3.7-8.2 |
3.9-9.4 |
|
10 years |
3.8-8.3 |
4.1-9.4 |
|
11 years |
3.9-8.4 |
4.3-9.4 |
|
12 years |
3.9-8.6 |
4.4-9.5 |
|
13 years |
4.0-8.7 |
4.6-9.6 |
|
14 years |
4.1-8.8 |
4.8-9.7 |
|
15 years |
4.2-8.9 |
5.0-9.8 |
|
16 years |
4.2-9.1 |
5.2-9.9 |
|
17 years |
4.3-9.2 |
5.4-10.0 |
|
18 years |
4.3-9.3 |
5.6-10.1 |
|
19 years |
4.4-9.5 |
5.7-10.3 |
|
20 years |
4.4-9.6 |
5.9-10.5 |
|
21 years |
4.4-9.8 |
6.0-10.6 |
|
22 years |
4.4-9.9 |
6.1-10.8 |
|
23 years |
4.4-10.1 |
6.2-11.0 |
|
24 years |
4.4-10.3 |
6.2-11.1 |
|
25 years |
4.4-10.4 |
6.3-11.3 |
|
26 years |
4.4-10.6 |
6.3-11.4 |
|
27 years |
4.3-10.8 |
6.4-11.6 |
|
28 years |
4.3-11.0 |
6.4-11.7 |
|
29 years |
4.3-11.2 |
6.4-11.8 |
|
30 years |
4.3-11.4 |
6.4-11.9 |
|
31 years |
4.4-11.6 |
6.4-12.1 |
|
32 years |
4.4-11.8 |
6.4-12.2 |
|
33 years |
4.4-11.9 |
6.4-12.3 |
|
34 years |
4.5-12.1 |
6.4-12.4 |
|
35 years |
4.5-12.2 |
6.4-12.6 |
|
36 years |
4.6-12.4 |
6.4-12.8 |
|
37 years |
4.6-12.5 |
6.4-12.9 |
|
38 years |
4.7-12.7 |
6.4-13.1 |
|
39 years |
4.7-12.8 |
6.4-13.2 |
|
40 years |
4.8-13.0 |
6.5-13.4 |
|
41 years |
4.8-13.2 |
6.5-13.5 |
|
42 years |
4.8-13.4 |
6.5-13.7 |
|
43 years |
4.9-13.5 |
6.6-13.9 |
|
44 years |
4.9-13.7 |
6.6-14.0 |
|
45 years |
4.9-13.9 |
6.6-14.2 |
|
46 years |
4.9-14.0 |
6.7-14.4 |
|
47 years |
4.9-14.2 |
6.7-14.5 |
|
48 years |
5.0-14.3 |
6.8-14.7 |
|
49 years |
5.0-14.4 |
6.8-14.9 |
|
50 years |
5.0-14.5 |
6.8-15.0 |
|
51 years |
5.1-14.6 |
6.8-15.2 |
|
52 years |
5.1-14.7 |
6.9-15.4 |
|
53 years |
5.1-14.8 |
6.9-15.5 |
|
54 years |
5.2-14.9 |
6.9-15.6 |
|
55 years |
5.2-15.0 |
6.9-15.7 |
|
56 years |
5.3-15.0 |
6.9-15.8 |
|
57 years |
5.3-15.1 |
6.9-15.9 |
|
58 years |
5.3-15.2 |
6.9-16.0 |
|
59 years |
5.4-15.2 |
6.9-16.0 |
|
60 years |
5.4-15.3 |
6.9-16.1 |
|
61 years |
5.4-15.4 |
7.0-16.2 |
|
62 years |
5.5-15.4 |
7.0-16.2 |
|
63 years |
5.5-15.5 |
7.0-16.3 |
|
64 years |
5.6-15.5 |
7.1-16.3 |
|
65 years |
5.6-15.6 |
7.1-16.3 |
|
66 years |
5.7-15.6 |
7.1-16.3 |
|
67 years |
5.7-15.7 |
7.2-16.3 |
|
68 years |
5.8-15.7 |
7.2-16.3 |
|
69 years |
5.9-15.7 |
7.2-16.3 |
|
70 years |
6.0-15.8 |
7.3-16.3 |
|
71 years |
6.1-15.8 |
7.3-16.3 |
|
72 years |
6.2-15.8 |
7.3-16.3 |
|
73 years |
6.3-15.9 |
7.3-16.3 |
|
74 years |
6.4-15.9 |
7.3-16.3 |
|
75 years |
6.5-15.9 |
7.3-16.3 |
|
76 years |
6.6-15.9 |
7.3-16.3 |
|
77 years |
6.7-16.0 |
7.4-16.3 |
|
78 years |
6.8-16.0 |
7.4-16.3 |
|
79 years |
6.9-16.0 |
7.5-16.3 |
|
80 years |
7.0-16.0 |
7.5-16.3 |
|
81 years |
7.1-16.0 |
7.7-16.2 |
|
82 years |
7.2-16.0 |
7.8-16.2 |
|
83 years |
7.2-16.0 |
7.9-16.2 |
|
84 years |
7.3-16.0 |
8.0-16.2 |
|
85 years |
7.3-16.0 |
8.2-16.2 |
|
>85 years |
7.4-16.0 |
8.3-16.2 |
Day(s) Performed
Monday through Friday
CPT Code Information
83090
Method Description
Total homocysteine is measured by stable isotope dilution microflow liquid chromatography tandem mass spectrometry.(Unpublished Mayo method)
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | OK |
| Gross icterus | OK |
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Forms
1. Biochemical Genetics Patient Information (T602)
2. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.